癌症患者对比增强CT扫描中椎体内强化的患病率与特征
本研究为单中心回顾性观察研究,回顾3个月内2572例癌症患者的对比增强体部CT,在发现椎旁静脉侧支循环且排除骨转移时寻找椎体内强化(IVE)。67例(2.8%)存在椎旁静脉侧支系统,其中21例(37%)有IVE;IVE多为线形(95.7%),80.8%位于C6至T4之间,88.9%位于椎体。作者认为IVE相对于注射侧和优势椎旁静脉系统侧的内侧或同侧位置及与椎旁静脉相连可能支持血管显影。
要点
- 癌症患者增强CT中,发现椎旁静脉侧支循环者37%存在椎体内强化(IVE),需与骨转移鉴别。
- IVE以线形为主(95.7%),多位于C6–T4(80.8%)和椎体(88.9%),73.1%位于注射侧同侧或内侧。
- IVE与椎旁静脉侧支及注射侧的位置关系(同侧或内侧)可能提示为血管内对比剂滞留而非转移。
核心结论
- 癌症患者增强CT中,存在椎旁静脉侧支循环者37%可检出椎体内强化;IVE相对于注射侧和优势椎旁静脉系统侧的内侧或同侧位置,以及与椎旁静脉相连的可能,可能支持血管显影。
研究设计与样本
- 单中心、回顾性观察研究,回顾3个月内癌症患者的2572例对比增强体部CT,在检出椎旁静脉侧支循环且排除骨转移时寻找IVE并分为线形或结节形。
关键影像表现/征象
- IVE表现为线形(199处,95.7%)或结节形(9处,4.3%),80.8%位于C6至T4之间,88.9%位于椎体,73.1%位于注射侧同侧或内侧。
诊断标准与关键数值
- 在2572例癌症患者增强CT中,67例(2.8%)有椎旁静脉侧支系统,其中21例(37%)检出IVE;共208处IVE累及75个椎体。
临床应用与阅片要点
- 阅片发现椎旁静脉侧支循环时,应寻找椎体内强化并与骨转移鉴别;IVE位于注射侧同侧或内侧、与优势椎旁静脉系统侧一致或与椎旁静脉相连时,可能支持血管显影。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
STUDY DESIGN: This was a single center, retrospective observational study.
OBJECTIVE: to investigate-in a cancer population-the prevalence and hallmarks of intravertebral enhancement (IVE) detected on contrast-enhanced CT.
SUMMARY OF BACKGROUND DATA: Intravertebral enhancements secondary to iodinated contrast stagnation have been described. Cancer patients have an increased risk of perivertebral venous thrombosis or stenosis secondary to several risk factors (cancer or drug induced hypercoagulability, deterioration of venous flow linked to catheter insertion, prolonged immobilization). In case of a high density lesion identified on CT, the diagnostic choice between metastasis and contrast media within bone marrow vessels may be an issue, especially as oncologic follow-up CT scans are usually performed with contrast medium injection.
METHODS: 2572 contrast-enhanced body CT scans performed in cancer patients over 3 months in the medical imaging department of a university hospital were retrospectively reviewed. IVE was sought when paravertebral venous collateral circulation was detected and bone metastasis ruled out and classified as linear or nodular. Their locations within vertebra, their relation to the injection side and the predominant collateral venous network side were evaluated.
RESULTS: Sixty-seven (2.8%) patients had a collateral paravertebral venous system and among them 21 had IVE (37%). There were 208 IVE locations involving 75 vertebrae. 199 IVE were linear-shaped (95.7%) and 9 nodular-shaped (4.3%). 80.8% were located between C6 and T4. 88.9% were localized in the vertebral body. 73.1% were located medially or ipsilateral to the injection side.
CONCLUSION: Intravertebral enhancement is found in 37% of the patients with paraspinal collateral venous circulation when a CT scan is performed for cancer. The ipsilateral or medial position of the IVE relative to the injection side and the side of the dominant perivertebral venous system, and the possibility of connecting the IVE to a paravertebral vein may be in favor of vascular opacification.
引用
- Rasselet B, Larbi A, Viala P, et al. Prevalence and characteristics of intravertebral enhancement on contrast-enhanced CT scans in cancer patients. Eur J Radiol. 2016. PMID: 28027734. doi:10.1016/j.ejrad.2016.10.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。